Literature DB >> 8564803

Growth hormone normalizes vertebral strength in ovariectomized rats.

C Eschen1, T T Andreassen.   

Abstract

Ten-month-old lactating breeders were ovariectomized and kept on a low calcium diet. One month after ovariectomy, the rats were dosed once daily for 6 months with either a low dose of growth hormone (GH) (0.05 mg), a high dose of GH (1 mg), estrogen plus gestagen (E-G) [17 beta-estradiol (0.1 mg); norethisterone-acetate (0.05 mg)], or a combination of GH and E-G. Mechanical competence, apparent dry density, apparent ash density and ash concentration were measured in the fourth lumbar vertebral body. The reduced mechanical strength, ash density and ash concentration found in the vertebral body of ovariectomized animals were prevented by the high dose of GH alone, or in combination with E-G. E-G alone partly prevented the decline in ash density and ash concentration, but did not affect the reduced mechanical strength seen after ovariectomy. Only minor effects were observed after treatment with the low dose of GH, alone or in combination with E-G. In conclusion this study shows that GH administration prevents the decline in mechanical strength and bone mineral density seen in rats after ovariectomy.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8564803     DOI: 10.1007/bf00302076

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  22 in total

1.  The ovariectomized, lactating rat as an experimental model for osteopenia: calcium metabolism and bone changes.

Authors:  J J Anderson; S C Garner; M H Mar; A Boass; S U Toverud; I Parikh
Journal:  Bone Miner       Date:  1990-10

2.  The aged rat model of ovarian hormone deficiency bone loss.

Authors:  D N Kalu; C C Liu; R R Hardin; B W Hollis
Journal:  Endocrinology       Date:  1989-01       Impact factor: 4.736

3.  Effects of combined and separate intermittent administration of low-dose human parathyroid hormone fragment (1-34) and 17 beta-estradiol on bone histomorphometry in ovariectomized rats with established osteopenia.

Authors:  V Shen; D W Dempster; R W Mellish; R Birchman; W Horbert; R Lindsay
Journal:  Calcif Tissue Int       Date:  1992-03       Impact factor: 4.333

4.  The positive effect of parathyroid hormone on femoral neck bone strength in ovariectomized rats is more pronounced than that of estrogen or bisphosphonates.

Authors:  C H Søgaard; T J Wronski; J E McOsker; L Mosekilde
Journal:  Endocrinology       Date:  1994-02       Impact factor: 4.736

5.  Estrogen and diphosphonate treatment provide long-term protection against osteopenia in ovariectomized rats.

Authors:  T J Wronski; C F Yen; K S Scott
Journal:  J Bone Miner Res       Date:  1991-04       Impact factor: 6.741

6.  Dose response of growth hormone on fracture healing in the rat.

Authors:  B Bak; P H Jørgensen; T T Andreassen
Journal:  Acta Orthop Scand       Date:  1990-02

7.  The effect on vertebral bone mass and strength of long term treatment with antiresorptive agents (estrogen and calcitonin), human parathyroid hormone-(1-38), and combination therapy, assessed in aged ovariectomized rats.

Authors:  L Mosekilde; C C Danielsen; J Gasser
Journal:  Endocrinology       Date:  1994-05       Impact factor: 4.736

8.  Parathyroid hormone is more effective than estrogen or bisphosphonates for restoration of lost bone mass in ovariectomized rats.

Authors:  T J Wronski; C F Yen; H Qi; L M Dann
Journal:  Endocrinology       Date:  1993-02       Impact factor: 4.736

9.  Loss of cancellous bone mass and connectivity in ovariectomized rats can be restored by combined treatment with parathyroid hormone and estradiol.

Authors:  V Shen; D W Dempster; R Birchman; R Xu; R Lindsay
Journal:  J Clin Invest       Date:  1993-06       Impact factor: 14.808

10.  Estrogens reduce bone loss in the ovariectomized, lactating rat model.

Authors:  S C Garner; J J Anderson; M H Mar; I Parikh
Journal:  Bone Miner       Date:  1991-10
View more
  2 in total

1.  Beneficial effects of conjugated linoleic acid and exercise on bone of middle-aged female mice.

Authors:  Jameela Banu; Arunabh Bhattacharya; Mizanur Rahman; Gabriel Fernandes
Journal:  J Bone Miner Metab       Date:  2008-08-30       Impact factor: 2.626

2.  Growth hormone protects against ovariectomy-induced bone loss in states of low circulating insulin-like growth factor (IGF-1).

Authors:  J Christopher Fritton; Kelly B Emerton; Hui Sun; Yuki Kawashima; Wilson Mejia; Yingjie Wu; Clifford J Rosen; David Panus; Mary Bouxsein; Robert J Majeska; Mitchell B Schaffler; Shoshana Yakar
Journal:  J Bone Miner Res       Date:  2010-02       Impact factor: 6.741

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.